Avant Technologies Inc. has rebranded as Avaí Bio, Inc., reflecting its focus on developing cell-based therapies for diabetes, age-related diseases, and healthy longevity. The company’s updated identity and information on its therapeutic pipeline can now be found on its new website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avant Technologies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN85808) on February 11, 2026, and is solely responsible for the information contained therein.